NCT00127153已完成3 期
A Comparative Study in Healthy Adults of the Safety, Tolerability, and Immunogenicity of V110 Formulated With Either All New Process Polysaccharides or All Current Process Polysaccharides
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 130
- 主要终点
- Immunogenicity
研究概览
简要总结
The purpose of this trial is to evaluate the safety, tolerability, and immunogenicity of an investigational pneumococcal vaccine in healthy adults.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double
入排标准
- 年龄范围
- 20 Years 至 40 Years（Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Males and females in good health, ages 20-40, with no history of pneumococcal vaccination
排除标准
- •Subjects with a recent febrile illness
- •Known or suspected immune dysfunction, conditions associated with immunosuppression, and receipt of immunosuppressive chemotherapy, including long-term corticosteroid therapy
结局指标
主要结局
Immunogenicity
次要结局
- Safety
研究者
相似试验
已完成
3 期
Study of Recombinant Modified Process Hepatitis B Vaccine in Older Adults (V232-059)(COMPLETED)Hepatitis BNCT00440531Merck Sharp & Dohme LLC540
已完成
1 期
Clinical Trial of Bilhvax,a Vaccine Candidate Against SchistosomiasisBilharziasisUrinary SchistosomiasisSchistosomiasisNCT01512277University Hospital, Lille24
已完成
1 期
Safety of and Immune Response to a DNA HIV Vaccine Followed by an Adenoviral Vaccine Boost Given Three Different Ways to HIV Uninfected AdultsHIV InfectionsNCT00384787National Institute of Allergy and Infectious Diseases (NIAID)90
招募中
早期 1 期
Study of KRAS Neoantigen mRNA Vaccine (ABO2102) in Patients With KRAS -Mutated Solid TumorsNCT06577532Ruijin Hospital56
已完成
3 期
Safety, Immunogenicity, and Relative Efficacy of H1N1 Vaccines in Adults Aged 18 Years and OlderInfluenzaNCT00979602GlaxoSmithKline4,048